EUVIMEDOpdag EUVIMED
Video/Audio

In Situ Generation of Claudin18.2-Specific CAR-T Cells via Lipid Nanoparticle–Mediated mRNA Delivery

Henghui Li, Jingyao Li, Ying Wang, Liang Chen

Journal of Visualized Experiments · 2026

DOI: 10.3791/71482 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2026. Written by Henghui Li and 3 co-authors. Institution: School of Medicine, Shanghai University. Major MEDLINE topics: Nanoparticles, RNA, Messenger, Lipids, Receptors, Chimeric Antigen.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Chimeric antigen receptor (CAR) T-cell therapy has achieved remarkable clinical success in hematological malignancies; however, its broader application is limited by high manufacturing costs and insufficient efficacy against solid tumors. To overcome these challenges, an in situ CAR-T cell generation strategy was developed based on lipid nanoparticle (LNP)-mediated delivery of CAR mRNA targeting Claudin18.2, enabling the transient production of CAR-T cells directly within tumor tissue. Following LNP transfection, activated T cells exhibited efficient surface expression of CARs. These transient CAR-T cells demonstrated potent cytotoxic activity against Claudin18.2-positive gastric carcinoma cell lines, including NUGC4 and NCI-N87, and produced significant antitumor efficacy in tumor-bearing mouse models. This protocol describes detailed procedures for in vitro transcription of CAR mRNA, LNP formulation, T-cell activation and transfection, CAR expression analysis, and in vitro and in vivo functional evaluation of CAR-T-mediated cytotoxicity. Taken together, this strategy provides a cost-effective and versatile platform for generating transient CAR-T cells and offers a promising approach for treating solid tumors.

Subjects

MeSH terms (MEDLINE)

NanoparticlesRNA, MessengerLipidsReceptors, Chimeric AntigenClaudinsT-LymphocytesImmunotherapy, AdoptiveAnimalsHumansMiceCell Line, TumorTransfectionStomach NeoplasmsLiposomes

Substances

RNA, MessengerLipidsReceptors, Chimeric AntigenClaudinsLipid NanoparticlesLiposomes

Authors and institutions

  • School of Medicine, Shanghai University.
  • School of Medicine, Shanghai University; lchen1@shu.edu.cn.

Cite

APA

Li, H., Li, J., Wang, Y., & Chen, L. (2026). In Situ Generation of Claudin18.2-Specific CAR-T Cells via Lipid Nanoparticle–Mediated mRNA Delivery. Journal of Visualized Experiments. https://doi.org/10.3791/71482

Vancouver

Li H, Li J, Wang Y, Chen L. In Situ Generation of Claudin18.2-Specific CAR-T Cells via Lipid Nanoparticle–Mediated mRNA Delivery. Journal of Visualized Experiments. 2026. doi:10.3791/71482

BibTeX
@article{Li2026,
  author = {Li, Henghui and Li, Jingyao and Wang, Ying and Chen, Liang},
  title = {In Situ Generation of Claudin18.2-Specific CAR-T Cells via Lipid Nanoparticle–Mediated mRNA Delivery},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/71482}
}
Start for free →